Identification of peripheral blood (PB) CD34+CD38−CD26+ cells was found to be diagnostic for CML in patients with a suspicious leukocytosis [34], supporting previous evidence and highlighting CD26 as a CML LSC biomarker. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.